Page 20 - The DHEA Debate - Life Extensions Magazine

32. Ferrari E, Casarotti D, Muzzoni B, et al. Age-related changes of the adrenal secretory
pattern: possible role in pathological brain aging. Brain Res Brain Res Rev. 2001 Nov;37(1-
3):294-300.

33. Wisniewski TL, Hilton CW, Morse EV, Svec F. The relationship of serum DHEAS and
cortisol levels to measures of immune function in Human Immunodeficiency Virus-related
illness. Am J Med Sci. 1993 Feb; 305(2):79-83.
34. Mattison JA, Lane MA, Roth GS, Ingram DK. Calorie restriction in rhesus monkeys. Exp
Gerontol. 2003 Jan-Feb; 38(1-2):35-46.
35. Catalina F, Kumar V, Milewich L, Bennett M. Food restriction-like effects of dehy-
droepiandrosterone: decreased lymphocyte numbers and functions with increased apoptosis.
Proc Soc Exp Biol Med. 1999 Sep;221(4):326-35.
36. Wang TT, Hursting SD, Perkins SN, Phang JM. Effects of dehydroepiandrosterone and
calorie restriction on the Bcl-2/Bax- mediated apoptotic pathway in p53-deficient mice. Cancer
Lett. 1997 Jun 3;116(1):61-9.

37. Roberts E. The importance of dehydroepiandrosterone sulfate in the blood of primates: a
longer and healthier life? Biochem Pharmacol. 1999 Feb 15;57(4):329-46.

38. Shock NW, et al, eds. Normal Human Aging: the Baltimore Longitudinal Study on Aging.
Washington, DC: US Government Printing Office;1984.
39. Roth GS, Lane MA, Ingram DK, et al. Biomarkers of calorie restriction may predict longevity
in humans. Science. 2002 Aug 2; 297(5582):811.
40. Ravaglia G, Forti P, Maioli F, et al.. The relationship of dehydroepiandrosterone sulfate
(DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results
from an Italian study on healthy free-living over-ninety-year- olds. J Clin Endocrinol Metab. 1996
Mar;81(3):1173-8.
41. Ravaglia G, Forti P, Maioli F, et al. Determinants of functional status in healthy Italian
nonagenarians and centenarians: a comprehensive functional assessment by the instruments of
geriatric practice. J Am Geriatr Soc. 1997 Oct;45(10):1196-202.
42. van den Beld AW, Lamberts SW. The male climacterium: clinical signs and symptoms of a
changing endocrine environment. Prostate Suppl. 2000;10:2-8.
43. Yang NC, Jeng KC, Ho WM, Hu ML. ATP depletion is an important factor in DHEA-induced
growth inhibition and apoptosis in BV-2 cells. Life Sci. 2002 Mar 15;70(17):1979-88.
44. Schulz S, Klann RC, Schonfeld S, Nyce JW. Mechanisms of cell growth inhibition and cell
cycle arrest in human colonic ade- nocarcinoma cells by dehydroepiandros- terone: role of
isoprenoid biosynthesis. Cancer Res. 1992 Mar 1;52(5):1372-6.

45. Loria RM. Immune up-regulation and tumor apoptosis by androstene steroids. Steroids.
2002 Nov;67(12):953-66.
46. Dashtaki R, Whorton AR, Murphy TM, Chitano P, Reed W, Kennedy TP.
Dehydroepiandrosterone and analopgs inhibit DNA binding of AP-1 and airway smooth muscle
proliferation. J Pharmacol Exp Ther. 1998 May; 285(2); 876-83.